go 6976 has been researched along with Cytomegalic Inclusion Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmermann, A | 1 |
| Wilts, H | 1 |
| Lenhardt, M | 1 |
| Hahn, M | 1 |
| Mertens, T | 1 |
1 other study available for go 6976 and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase.
Topics: Antiviral Agents; Carbazoles; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Enzyme Inhibit | 2000 |